Valiant Organics Ltd
Valiant Organics Ltd Q3 FY26 Results & Presentation Highlights: Revenue, Margins & Order Book
Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Valiant Organics Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn) - Q3-FY26 Standalone Revenue from Operations: INR 1,591 Mn, down 14.9% YoY (Q3-FY25: INR 1,869 Mn) - Key chemistry sales volumes (Metric Tons, MT) for Q3-FY26 vs Q3-FY25: - Chlorination: decreased from 380 MT to 362 MT - Hydrogenation: decreased from 286 MT to 258 MT - Ammonolysis: steady around 93 MT (Q3-FY25: 97 MT) - Others: slight decrease from 97 MT to 93 MT - Revenue breakup Q3-FY26 by chemistry: Chlorination 23%, Hydrogenation 43%, Ammonolysis 28%, Others 6% - The presentation does not state any explicit forward-looking revenue or volume outlook. Q3-FY26 Consolidated Financials: - EBITDA: INR 156 Mn, up 1.3% YoY from INR 154 Mn.
From Valiant Organics Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn)
- Q3-FY26 Standalone Revenue from Operations: INR 1,591 Mn, down 14.9% YoY (Q3-FY25: INR 1,869 Mn)
- Key chemistry sales volumes (Metric Tons, MT) for Q3-FY26 vs Q3-FY25:
- Chlorination: decreased from 380 MT to 362 MT
- Hydrogenation: decreased from 286 MT to 258 MT
- Ammonolysis: steady around 93 MT (Q3-FY25: 97 MT)
- Others: slight decrease from 97 MT to 93 MT
- Revenue breakup Q3-FY26 by chemistry: Chlorination 23%, Hydrogenation 43%, Ammonolysis 28%, Others 6%
2 more points management made on revenue & sales performance
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Valiant Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics Ltd's management said in earlier quarters
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q1 FY23 earnings call →
- Q4 FY22 earnings call →
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q3 FY26)
Revenue from Operations for Q3FY26: ₹331.30 crore, compared to ₹320.59 crore in Q3FY25 (consolidated) and ₹304.68 crore in Q3FY25 (standalone). Key investor pre
- Vidhi Specialty Food Ingredients Ltd (Q3 FY26)
94.5 Cr, down 4.1% YoY from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY26 investor presentation — and how it ranks
- Bodal Chemicals Ltd (Q3 FY26)
5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. Key investor presentation takeaways from Bodal Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks against s
- Chemcon Speciality Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations:** ₹57.3 Cr (vs ₹54.4 Cr in Q3 FY25) — approx. Key investor presentation takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY
Frequently Asked Questions
What were Valiant Organics Ltd Q3 FY26 results?
Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn) - Q3-FY26 Standalone Revenue from Operations: INR 1,591 Mn, down 14.9% YoY (Q3-FY25: INR 1,869 Mn) - Key chemistry sales volumes (Metric Tons, MT) for Q3-FY26 vs Q3-FY25: - Chlorination: decreased from 380 MT to 362 MT - Hydrogenation: decreased from 286 MT to 258 MT - Ammonolysis: steady around 93 MT (Q3-FY25: 97 MT) - Others: slight decrease from 97 MT to 93 MT - Revenue breakup Q3-FY26 by chemistry: Chlorination 23%, Hydrogenation 43%, Ammonolysis 28%, Others 6% - The presentation does not state any explicit forward-looking revenue or volume outlook. Q3-FY26 Consolidated Financials: - EBITDA: INR 156 Mn, up 1.3% YoY from INR 154 Mn.
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Is Valiant Organics Ltd planning capital expenditure?
The presentation does not specifically describe any capex plans, capacity expansion projects, new plants, or related investment amounts, status, or timelines.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.